Detecting depression in Parkinson disease A systematic review and meta-analysis
Zahra Goodarzi,Kelly Mrklas,Derek J. Roberts,Nathalie Jette,Tamara Pringsheim,Jayna Holroyd-Leduc +5 more
152
TL;DR: There are several valid tools for detecting depression in patients with PD and practitioners should choose one that fits their clinical practice, although all estimates had heterogeneity.
read more
Abstract: Background: Failure to detect depression in patients with Parkinson disease (PD) can lead to worsened outcomes for patients and caregivers. Accurate identification of depression would enable practitioners to provide comprehensive care for their patients with PD. Methods: Our objective was to examine the diagnostic accuracy of tools for detecting depression in adult outpatients with PD. We searched MEDLINE, PsycINFO, and EMBASE (inception to December 1, 2015), gray literature, and bibliographies of included studies. The pooled prevalence of depression across studies and diagnostic accuracy estimates were calculated using random-effects models. Diagnostic accuracy estimates were calculated across the best-reported cutoffs from each study and across specific cutoffs, when feasible. Results: Out of 8,184 citations, 21 studies were included, evaluating 24 tools, with 4 amenable to meta-analysis. The pooled prevalence of major depression was 22.9% (95% confidence interval [CI] 18.1–27.7). The 15-item Geriatric Depression Scale (GDS-15) had a pooled sensitivity of 0.81 (95% CI 0.64–0.91) and specificity of 0.91 (95% CI 0.87–0.94). The most sensitive cutoff for the GDS-15 was 5 at 0.91 (95% CI 0.83–1.00). The Beck Depression Inventory I/Ia had a pooled sensitivity of 0.79 (95% CI 0.61–0.90) and specificity of 0.85 (95% CI 0.79–0.90). The Montgomery-Asberg Depression Rating Scale yielded a pooled sensitivity of 0.77 (95% CI 0.69–0.83) and specificity of 0.92 (95% CI 0.79–0.97). The Unified Parkinson9s Disease Rating Scale had a pooled sensitivity of 0.72 (95% CI 0.64–0.79) and specificity of 0.80 (95% CI 0.70–0.87). All estimates had heterogeneity. Conclusions: There are several valid tools for detecting depression in patients with PD. Practitioners should choose one that fits their clinical practice.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
A practical approach to detection and treatment of depression in Parkinson disease and dementia
Zahra Goodarzi,Zahinoor Ismail +1 more
- 01 Apr 2017
TL;DR: Despite variable evidence, the use of nonpharmacologic strategies to manage depression is suggested and pharmacologic management is guided by modest evidence in PD and dementia, but also informed by the management of late-life depression.
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease
Thomas F. Tropea,Sharon X. Xie,Jacqueline Rick,Lana M. Chahine,Nabila Dahodwala,Jimit Doshi,Christos Davatzikos,Leslie M. Shaw,Vivianna M. Van Deerlin,John Q. Trojanowski,Daniel Weintraub,Daniel Weintraub,Alice Chen-Plotkin +12 more
TL;DR: The objective of this study was to find baseline predictors of cognitive decline in longitudinally followed, nondemented Parkinson's disease patients.
The Effects of Group Therapeutic Singing on Cortisol and Motor Symptoms in Persons With Parkinson's Disease
Elizabeth L. Stegemöller,Andrew Zaman,Mack C. Shelley,Bhavana Patel,Ahmad El Kouzi,Elizabeth A. Shirtcliff +5 more
TL;DR: In this paper, the authors examined the acute effects of 1 h of group therapeutic singing (GTS) on physiological measures of stress and clinical motor symptoms in persons with Parkinson's disease (PD) and posit that improvement in motor symptoms after GTS may be related to stress reduction.
Drug treatment strategies for depression in Parkinson disease.
TL;DR: This article covers the pharmacological treatment of depression in PD, which involves standard antidepressant treatment such as selective serotonin reuptake inhibitors, tricyclic antidepressants, serotonin and norepinephrine reuptakes inhibitors, and monoamine oxidase inhibitors.
Risk Factors of Non-motor Symptoms in Different Stages of Parkinson’s Disease
Jinlan Jiang,Wei Jin,Zengpeng Lv,Xu Zi,Feng Liang,Lihong Li +5 more
- 24 Aug 2023
TL;DR: Risk factors of non-motor symptoms in different stages of Parkinson’s disease vary across clinical features and medication use. Pain and constipation are the most common non-motor symptoms.
References
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
TL;DR: The CES-D scale as discussed by the authors is a short self-report scale designed to measure depressive symptomatology in the general population, which has been used in household interview surveys and in psychiatric settings.
Related Papers (5)
Christopher G. Goetz,Barbara C. Tilley,Stephanie R. Shaftman,Glenn T. Stebbins,Stanley Fahn,Pablo Martinez-Martin,Werner Poewe,Cristina Sampaio,Matthew B. Stern,Richard Dodel,Bruno Dubois,Robert G. Holloway,Joseph Jankovic,Jaime Kulisevsky,Anthony E. Lang,Andrew J. Lees,Sue Leurgans,Peter A. LeWitt,David L. Nyenhuis,C. Warren Olanow,Olivier Rascol,Anette Schrag,Jeanne A. Teresi,Jacobus J. van Hilten,Nancy R. LaPelle,Pinky Agarwal,Saima Athar,Yvette Bordelan,Helen Bronte-Stewart,Richard Camicioli,Kelvin L. Chou,Wendy Cole,Arif Dalvi,Holly Delgado,Alan Diamond,Jeremy P.R. Dick,John E. Duda,Rodger J. Elble,Carol Evans,V. G. H. Evidente,Hubert H. Fernandez,Susan H. Fox,Joseph H. Friedman,Robin D. Fross,David A. Gallagher,Deborah A. Hall,Neal Hermanowicz,Vanessa K. Hinson,Stacy Horn,Howard I. Hurtig,Un Jung Kang,Galit Kleiner-Fisman,Olga Klepitskaya,Katie Kompoliti,Eugene C. Lai,Maureen L. Leehey,Iracema Leroi,Kelly E. Lyons,Terry McClain,Steven W. Metzer,Janis M. Miyasaki,John C. Morgan,Martha Nance,Joanne Nemeth,Rajesh Pahwa,Sotirios A. Parashos,Jay S. Schneider,Kapil D. Sethi,Lisa M. Shulman,Andrew Siderowf,Monty Silverdale,Tanya Simuni,Mark Stacy,Robert Malcolm Stewart,Kelly L. Sullivan,David M. Swope,Pettaruse M. Wadia,Richard Walker,Ruth H. Walker,William J. Weiner,Jill Wiener,Jayne R. Wilkinson,Joanna M. Wojcieszek,Summer C. Wolfrath,Frederick Wooten,Allen Wu,Theresa A. Zesiewicz,Richard M. Zweig +87 more